The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (21 analysts) rates it buy, with a mean price target of $90.
TransUnion
TRU · the NYSE · USD · Market cap $14.7B · 13,500 employees
TransUnion operates as a global consumer credit reporting agency that provides risk and information solutions.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
TransUnion holds its Markdown at $76.95. The statistical read favours the sellers, held for 64 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 64 days |
| Price at the screen | $76.95 |
| Valuation | 20.30 trailing · 13.79 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.54 |
Five Screens, Shown in Full
Does not pass. Excluded industry: Financial Data & Stock Exchanges
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Excluded industry: Financial Data & Stock Exchanges | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 19.3% margin of safety to the base estimate.
Third-party analyst targets: 21 covering, consensus Buy. The average target sits +30% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCredit Data Giant Trips on Ethical Line
Every time a family checks its mortgage rate or a freelancer applies for a card, TransUnion sits in the middle of that decision. The business grows revenue at 14 percent a year, earns a 15 percent profit margin and posts 15 percent ROE, yet the numbers do not matter here. It fails our ethical screen because the entire sector, financial data and stock exchanges, sits on the excluded list.
That screen exists for a reason. We are not paid to weigh whether credit bureaus create value or whether a 14.3 times forward multiple and a narrow moat look attractive next to a 9 percent margin of safety. The industry itself is off limits, full stop.
Valuation and growth can shift, yet the ethical filter does not. The stock may keep trading near analyst targets around 90 dollars, but we stay away on principle. Analysis, not advice.
| Forward P/E | 13.8xfairly priced for its growth rate |
| Trailing P/E | 20.3xa premium valuation |
| EPS, trailing | 3.79 |
| EPS, forward | 5.58 |
| Revenue growth | +14.9%steady growth |
| Profit margin | 15.1%healthy profit margins |
| Return on equity | 15.6%a solid return on shareholder capital |
| FCF yield | 5.48% |
| Dividend yield | 76.00% |
| Debt to equity | 1.13a meaningful debt load worth watching |
| Current ratio | 1.90healthy short-term liquidity |
| Beta | 1.54much more volatile than the market |
| Short interest, float | 0.05% |
| 52-week range | 63.37 - 95.51 |
| Moat | NARROW |
| Market cap | $14.7B |
| Employees | 13,500 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeTRU trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 19.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (21 analysts) rates it buy, with a mean price target of $90.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (21 analysts) rates it buy, with a mean price target of $90.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | Achanta Venkat | EVP, Chief Tech, Data, Analy. | S - Sale | 23,287 | $1,793,099 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-24 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-24 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-24 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-07 | Gil Cisneros | Democrat | sell | 15K–50K |
| 2026-08-07 | Gil Cisneros | Democrat | sell | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $69.87 | -2.9% | $0.13 | $973 | -2.7% |
| 2 months | $67.75 | +0.2% | $0.13 | $1,003 | +0.3% |
| 3 months | $69.46 | -2.3% | $0.13 | $979 | -2.1% |
| 6 months | $85.46 | -20.6% | $0.25 | $797 | -20.3% |
| 1 year | $88.35 | -23.2% | $0.48 | $773 | -22.7% |
| 2 years | $71.50 | -5.1% | $0.92 | $962 | -3.8% |
| 3 years | $72.07 | -5.9% | $1.34 | $960 | -4.0% |
| 5 years | $103.74 | -34.6% | $2.14 | $675 | -32.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TRU does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.